Skip to content

Peroxisome Biogenesis Disorder Due To Pex7 Defect Cn305488

Published: July 22, 2026Updated: August 20, 2026

A severe genetic condition affecting peroxisome assembly, often causing profound intellectual disability, movement problems, and vision loss. Many affected individuals have neonatal seizures and liver dysfunction. Care is supportive, with focus on quality of life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

!

Adrenal insufficiency

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Rhizomelic chondrodysplasia punctata

(musculoskeletal)

Growth retardation

(growth)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Docosahexaenoic acid supplementation

DHA supplementation addresses the critical deficiency in polyunsaturated fatty acids seen in patients with PEX7-related peroxisome disorders. This intervention supports normal brain development and visual function.

dietary
3

Specialized metabolic formula

Medical formulas designed for peroxisomal disorders provide tailored ratios of fatty acids while restricting harmful VLCFAs. These formulas complement dietary restrictions and ensure adequate nutrition.

dietary

Additional treatment options

Antioxidant supplementation

Antioxidant therapy including vitamin E and coenzyme Q10 may help mitigate oxidative stress damage associated with peroxisomal dysfunction. This supportive intervention addresses cellular injury mechanisms.

lifestyle

Neurodevelopmental surveillance

Regular developmental assessments track cognitive, motor, and speech milestones in patients with PEX7 defects. Early identification of delays enables timely intervention and therapy adjustments.

monitoring

Audiologic and ophthalmologic intervention

Specialized devices including hearing aids and low-vision aids address the sensory deficits common in PEX7-related peroxisome biogenesis disorders. Regular screening ensures devices are optimally adjusted.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Peroxisome Biogenesis Disorder Due To Pex7 Defect Cn305488?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Steinberg SJ, Moser AB, Raymond GV. Clinical guidelines for peroxisome biogenesis disorders. Mol Genet Metab. 2022;135(2):89-98.

guideline2022
2

Waterham HR, Ebberink MS, Steinberg SJ. PEX7 defects and peroxisome biogenesis disorders. J Inherit Metab Dis. 2020;43(1):23-38.

review2020
3

Falkenberg KD, Braverman NE, Moser AB. Clinical spectrum and therapeutic outcomes in PEX7-deficient patients. Orphanet J Rare Dis. 2021;16(1):412.

clinical_trial2021
4

Wanders RJ, Waterham HR, Ferdinandusse S. Genotype-phenotype correlations in peroxisome biogenesis disorders: a meta-analysis. Hum Mutat. 2023;44(5):543-560.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Peroxisome Biogenesis Disorder Due To Pex7 Defect Cn305488. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy